Whey Protein Lycosome Formulation Improves Vascular Functions and Plasma Lipids with Reduction of Markers of Inflammation and Oxidative Stress in Prehypertension

Table 4

Effect on cardiovascular parameters.

Product	Pulse rate per min	ABI	FMD (%)	Blood pressure, in mm Hg		StO2, % O2/min
				Systolic	Diastolic
WP baseline after 1 month (n = 10)	71.0 ± 3.9	1.05 ± 0.04	9.4 ± 1.1	137 ± 9.7	86.1 ± 5.0	10.2 ± 0.9
	70.6 ± 2.8	1.06 ± 0.03	9.5 ± 1.2	135 ± 8.8	83.6 ± 3.2	10.3 ± 1.1
	P > 0.05	P > 0.05	P > 0.05	P > 0.05	P > 0.05	P > 0.05
Lycopene baseline after 1 month (n = 10)	73.1 ± 3.8	1.09 ± 0.05	10.5 ± 1.1	132 ± 3.6	86 ± 3.4	13.1 ± 0.8
	71.5 ± 4.9	1.01 ± 0.07	11.1 ± 0.9	130 ± 6.5	83 ± 4.8	14.7 ± 0.9
	P > 0.05	P > 0.05	P > 0.05	P > 0.05	P > 0.05	P > 0.05
WPL baseline after 1 month (n = 10)	68.3 ± 3.2	0.97 ± 0.07	10.3 ± 0.8	131 ± 8.0	81 ± 5.0	11.4 ± 0.6
	67.9 ± 2.9	0.97 ± 0.08	12.9 ± 0.8	124 ± 7.4	77 ± 4.1	16.4 ± 0.8
	P > 0.05	P > 0.05	P < 0.01*	P < 0.01*	P < 0.01*	P < 0.01*
Placebo baseline after 1 month (n = 10)	65.2 ± 5.1	0.97 ± 0.07	10.2 ± 0.9	135 ± 8.5	84 ± 4.1	11.5 ± 0.7
	66.4 ± 4.6	0.97 ± 0.08	10.0 ± 1.2	136 ± 9.6	83.5 ± 3.3	12.2 ± 0.4
	P > 0.05	P > 0.05	P > 0.05	P > 0.05	P > 0.05	P > 0.05